-
3
-
-
0034913232
-
Barriers to compliance with prophylaxis therapy in haemophilia
-
Hacker MR, Geraghty S, Manco-Johnson M. Barriers to compliance with prophylaxis therapy in haemophilia. Haemophilia 2001; 7: 392-396.
-
(2001)
Haemophilia
, vol.7
, pp. 392-396
-
-
Hacker, M.R.1
Geraghty, S.2
Manco-Johnson, M.3
-
4
-
-
34547631468
-
The risk associated with indwelling catheters in children with haemophilia
-
Ljung R. The risk associated with indwelling catheters in children with haemophilia. Br J Haematol 2007; 138: 580-586.
-
(2007)
Br J Haematol
, vol.138
, pp. 580-586
-
-
Ljung, R.1
-
5
-
-
73949135703
-
Longer-acting factor VIII to overcome limitations in haemophilia management: The PEGylated liposomes formulation issue
-
Di Minno G, Cerbone AM, Coppola A, et al. Longer-acting factor VIII to overcome limitations in haemophilia management: the PEGylated liposomes formulation issue. Haemophilia 2010; 16 (Suppl 1): 2-6.
-
(2010)
Haemophilia
, vol.16
, Issue.SUPPL. 1
, pp. 2-6
-
-
Di Minno, G.1
Cerbone, A.M.2
Coppola, A.3
-
6
-
-
20444503381
-
Factor VIII efficient and specific noncovalent binding to PEGylated liposomes enables prolongation of its circulation time and haemostatic efficacy
-
Baru M, Carmel-Goren L, Barenholz Y, et al. Factor VIII efficient and specific noncovalent binding to PEGylated liposomes enables prolongation of its circulation time and haemostatic efficacy. Thromb Haemost 2005; 93: 1061-1068.
-
(2005)
Thromb Haemost
, vol.93
, pp. 1061-1068
-
-
Baru, M.1
Carmel-Goren, L.2
Barenholz, Y.3
-
7
-
-
38349083504
-
Safety and pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe hemophilia A
-
Powell JS, Nugent DJ, Harrison JA, et al. Safety and pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe hemophilia A. J Thromb Haemost 2008; 6: 277-283.
-
(2008)
J Thromb Haemost
, vol.6
, pp. 277-283
-
-
Powell, J.S.1
Nugent, D.J.2
Harrison, J.A.3
-
8
-
-
33845241302
-
Prolonged bleeding-free period following prophylactic infusion of recombinant factor VIII reconstituted with pegylated liposomes
-
Spira J, Plyushch OP, Andreeva TA, Andreev Y. Prolonged bleeding-free period following prophylactic infusion of recombinant factor VIII reconstituted with pegylated liposomes. Blood 2006; 108: 3668-3673.
-
(2006)
Blood
, vol.108
, pp. 3668-3673
-
-
Spira, J.1
Plyushch, O.P.2
Andreeva, T.A.3
Andreev, Y.4
-
9
-
-
51349110498
-
Evaluation of liposomal dose in recombinant factor VIII reconstituted with pegylated liposomes for the treatment of patients with severe haemophilia A
-
Spira J, Plyushch OP, Andreeva TA, Khametova RN. Evaluation of liposomal dose in recombinant factor VIII reconstituted with pegylated liposomes for the treatment of patients with severe haemophilia A. Thromb Haemost 2008; 100: 429-434.
-
(2008)
Thromb Haemost
, vol.100
, pp. 429-434
-
-
Spira, J.1
Plyushch, O.P.2
Andreeva, T.A.3
Khametova, R.N.4
-
10
-
-
51249103798
-
Infusion rates of recombinant FVIII-FS with PEGylated liposomes in haemophilia A
-
Martinowitz U, Lalezari S, Luboshitz J, Lubetsky A, Spira J. Infusion rates of recombinant FVIII-FS with PEGylated liposomes in haemophilia A. Haemophilia 2008; 14: 1122-1124.
-
(2008)
Haemophilia
, vol.14
, pp. 1122-1124
-
-
Martinowitz, U.1
Lalezari, S.2
Luboshitz, J.3
Lubetsky, A.4
Spira, J.5
-
11
-
-
38349109840
-
Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: Experience in the standard clinical setting
-
Musso R, Santagostino E, Faradji A, et al. Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: experience in the standard clinical setting. Thromb Haemost 2008; 99: 52-58.
-
(2008)
Thromb Haemost
, vol.99
, pp. 52-58
-
-
Musso, R.1
Santagostino, E.2
Faradji, A.3
-
12
-
-
70449601973
-
Efficacy assessment of a new clotting factor concentrate in haemophilia A patients, including prophylactic treatment
-
Den Uijl I, Mauser-Bunschoten EP, Roosendaal G, Schutgens R, Fischer K. Efficacy assessment of a new clotting factor concentrate in haemophilia A patients, including prophylactic treatment. Haemophilia 2009; 15: 1215-1218.
-
(2009)
Haemophilia
, vol.15
, pp. 1215-1218
-
-
Den Uijl, I.1
Mauser-Bunschoten, E.P.2
Roosendaal, G.3
Schutgens, R.4
Fischer, K.5
-
13
-
-
47649131839
-
Plasma and albumin-free recombinant factor VIII: Pharmacokinetics, efficacy and safety in previously treated pediatric patients
-
Blanchette VS, Shapiro AD, Liesner RJ, et al. Plasma and albumin-free recombinant factor VIII: pharmacokinetics, efficacy and safety in previously treated pediatric patients. J Thromb Haemost 2008; 6: 1319-1326.
-
(2008)
J Thromb Haemost
, vol.6
, pp. 1319-1326
-
-
Blanchette, V.S.1
Shapiro, A.D.2
Liesner, R.J.3
-
14
-
-
84871386504
-
World Federation of Hemophilia Physical Examination Score (also called the Gilbert Score)
-
Orthopedic Advisory Committee of WFH. Available at: Accessed May 11, 2012
-
Gilbert M, Orthopedic Advisory Committee of WFH. World Federation of Hemophilia Physical Examination Score (also called the Gilbert Score). World Federation of Hemophilia. Available at: http://www.wfh.org/2/7/7_0_Assess ment_Tools_Gilbert_Score.htm. Accessed May 11, 2012.
-
World Federation of Hemophilia
-
-
Gilbert, M.1
|